Preface: COVID-19 Scenario Modeling Hubs

Affiliations

¹ Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; International Vaccine Access Center, Baltimore, MD, USA.
² The Roux Institute Northeastern University, Portland, MA, USA; Laboratory for the Modeling of Biological and Socio-technical Systems Network Science Institute Northeastern University, Boston, MA, USA.
³ University of Southern California, Los Angeles, CA, USA.
⁴ Biocomplexity Institute, University of Virginia, Charlottesville, VA, USA.
⁵ Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; International Vaccine Access Center, Baltimore, MD, USA.
⁶ Fogarty International Center, National Institutes of Health, Bethesda, MD, USA.

Free article

Editorial

Sara L Loo et al. Epidemics. 2024 Sep.

Free article

. 2024 Sep:48:100788.

doi: 10.1016/j.epidem.2024.100788. Epub 2024 Aug 24.

¹ Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; International Vaccine Access Center, Baltimore, MD, USA.
² The Roux Institute Northeastern University, Portland, MA, USA; Laboratory for the Modeling of Biological and Socio-technical Systems Network Science Institute Northeastern University, Boston, MA, USA.
³ University of Southern California, Los Angeles, CA, USA.
⁴ Biocomplexity Institute, University of Virginia, Charlottesville, VA, USA.
⁵ Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; International Vaccine Access Center, Baltimore, MD, USA.
⁶ Fogarty International Center, National Institutes of Health, Bethesda, MD, USA.

No abstract available

Keywords: COVID-19; Infectious disease modeling; Multi-model hubs; Scenario modeling.

Conflict of interest statement

Declaration of Competing Interest None.